Estradiol transdermal - Johnson & Johnson
Alternative Names: Evopad; Evorel; SystenLatest Information Update: 19 Dec 2021
At a glance
- Originator Johnson & Johnson
- Developer Janssen-Cilag; Johnson & Johnson
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome